Table 3.

Prevalence of baseline anemia related to different characteristics of cervical cancer patients in TASH cancer center, Ethiopia (n = 634)

Variables	Code	Baseline anemia
		Yes		No
		Frequency	(%)	Frequency	(%)
Age	< 30	30	50.85	29	49.15
	30–39	44	36.97	75	63.02
	40–49	95	57.92	69	42.07
	50–59	87	56.13	68	43.87
	≥ 60	67	48.91	70	51.09
Residence	Urban	184	51.83	171	48.17
	Rural	139	49.82	140	50.18
Region	Amhara	83	51.55	78	48.45
	Oromia	103	50.74	100	49.26
	Tigray	18	78.26)	5	21.74
	SNNP	32	53.33	28	46.67
	Addis Ababa	77	46.11	90	53.89
	Others	10	50.00	10	50.00
Occupation	Gov’t employee	42	49.41	43	50.59
	Merchant	40	54.79	33	45.20
	Farmer	60	51.28	57	48.71
	House wife	133	49.44	136	50.56
	Others	48	53.33	42	46.67
Substance use	User	73	68.86	33	31.13
	None user	250	47.35	278	52.65
Children	No child	8	40.00	12	60.00
	One	20	48.78	21	51.22
	Two	42	45.65	50	54.35
	Three	115	53.49	100	46.51
	More than 3	138	51.88	128	48.12
Marital status	Married	218	53.56	189	46.44
	Single	13	41.94	18	58.06
	Widowed	48	48.98	50	51.02
	Divorced	44	44.89	54	55.10
Stage	Stage I	26	41.26	37	58.73
	Stage II	70	44.31	88	55.69
	Stage III	118	46.27	137	53.72
	Stage IV	109	68.99	49	31.01
Histopathology	Squamous cell	299	52.09	275	47.91
	Adenocarcinoma	24	40.00	36	60.00
Comorbidity	Yes	152	71.70)	60	28.30
	No	171	40.52	251	59.48
Comorbidity types (n = 212)	HIV	90	76.27	28	23.73
	Hypertension	31	63.27	18	36.73
	Others	21	44.68	16	34.04